• Smoothened in Honeybee Olfaction: Study Insights

  2026-08-14

  Guo et al. characterize Apis mellifera Smoothened (Smo) and connect its pharmacological modulation with olfactory receptor expression, electroantennographic responses, and odor-guided behavior. The study provides a useful insect model for testing Hedgehog pathway function while emphasizing the need for careful interpretation when translating Smo biology across species.

• Ruthenium Red for Calcium Signaling Workflows

  2026-08-13

  Ruthenium Red is a practical Ca2+ transport inhibitor for separating calcium-dependent effects from cytoskeletal and mechanical inputs in autophagy experiments. This workflow-focused guide connects the product’s membrane-level activity with compression-induced autophagy, mitochondrial calcium uptake inhibition, and neurogenic inflammation models while emphasizing controls and troubleshooting.

• GS-4997 in Lupus Nephritis Tubulointerstitial Injury

  2026-08-13

  The 2024 FASEB Journal study identifies ASK1 signaling as a modifiable driver of tubulointerstitial injury in lupus nephritis. In lupus-prone mice and LPS-stimulated human tubular epithelial cells, GS-4997 reduced renal inflammation, fibrosis, and injury while suppressing the downstream p38/JNK pathway, providing a mechanistic basis for further preclinical investigation.

• Dabigatran etexilate: Assay Workflow Guide

  2026-08-12

  This scenario-based guide explains how Dabigatran etexilate, SKU A8381, can support thrombin-centered coagulation studies while avoiding common confounding factors in cell viability and cytotoxicity workflows. It covers mechanism, solvent compatibility, concentration design, interpretation, and practical supplier-selection criteria.

• Amyloid Beta-Peptide (1-40): Applied Workflows

  2026-08-12

  Build more reproducible Alzheimer’s disease assays with a defined Aβ40 reagent, controlled aggregation timelines, and surface-sensitive readouts. This guide connects amyloid fibril formation studies with membrane, spectroscopy, and cell-based neurotoxicity workflows while highlighting calcium-dependent experimental variables.

• DEV VP26 and the Actin–Myosin II Network

  2026-08-11

  The 2025 reference study combines VP26 affinity proteomics with genetic and pharmacological perturbation to identify the host actin–myosin II network as a regulator of duck enteritis virus proliferation. Its strongest mechanistic evidence centers on MYH9, while actin polymerization inhibitors and myosin II inhibition provide a framework for testing cytoskeletal dependency in infection models.

• Methylprednisolone: Assays and Bone-Loss Models

  2026-08-10

  Learn how to use Methylprednisolone as a controlled inflammatory trigger in macrophage, PBMC, skin-culture, and glucocorticoid-induced osteonecrosis workflows. The guide combines practical dosing, solvent handling, bone-resorption readouts, and troubleshooting with findings from a rat femoral-head study.

• GSK621: AMPK Signaling from AML to Immunometabolism

  2026-08-09

  Explore how the AMPK agonist GSK621 can connect energy sensing, AML biology, and immunometabolic assay design. This article translates recent lysosomal AMPK findings into a rigorous framework for interpreting pathway, metabolic, and phenotype-level readouts.

• 5hmC in Rice Drought Response: Context Matters

  2026-08-08

  Yan and colleagues provide the first single-base-resolution map of 5-hydroxymethylcytosine in rice and show that its abundance, genomic distribution, and transcriptional associations change during drought and rehydration. The study positions 5hmC as a context-dependent regulatory mark and offers a framework for integrating DNA hydroxymethylation assays with transcriptomic analysis in plant stress research.

• Eicosapentaenoic Acid: Applied Research Workflows

  2026-08-07

  Eicosapentaenoic Acid (EPA) supports controlled studies of membrane remodeling, lipoprotein oxidation, and endothelial behavior. This workflow also shows how to translate an arachidonic-acid immune study into a carefully bounded EPA comparison without overstating vaccine-adjuvant evidence.

• I-BET-762: Enabling Translational Leaps in BET-Targeted Rese

  2026-08-07

  This article explores the mechanistic and translational frontiers of I-BET-762, a potent and selective BET inhibitor, in the context of ferroptosis, inflammation, and cancer biology. Bridging recent discoveries with protocol guidance, it demonstrates how I-BET-762 empowers researchers to dissect BRD4-regulated cell death and transcriptional programs, while addressing practical considerations and future outlooks for preclinical and translational impact.

• Tyrothricin: Advanced Mechanistic Insights for Antimicrobial

  2026-08-06

  Explore the peptide antibiotic mixture Tyrothricin and its unique, multi-modal antimicrobial mechanism. This article delves into underexplored mechanistic links, protocol parameters, and translational relevance, providing new depth for researchers in infection biology.

• HDAC3–NRF2–GPX4 Axis Controls Ferroptosis in Colorectal Canc

  2026-08-06

  This study identifies histone deacetylase 3 (HDAC3) as a key epigenetic suppressor of ferroptosis in colorectal cancer cells via the NRF2–GPX4 signaling pathway. The findings illuminate a critical mechanism of ferroptosis resistance and suggest new therapeutic angles for sensitizing tumors to ferroptosis-based interventions.

• GDC-0068 (RG7440): Unraveling Nuclear mTORC1 via Pan-AKT Inh

  2026-08-05

  Explore how APExBIO’s GDC-0068 (RG7440), a pan-AKT inhibitor, empowers translational researchers to interrogate spatially distinct pools of mTORC1, particularly its nuclear functions, bringing new mechanistic clarity and strategic guidance to PI3K/Akt/mTOR pathway research in tumorigenesis.

• Catalpol: Translational Leverage for Disease Modeling & Ther

  2026-08-05

  Catalpol, a natural iridoid glycoside derived from Rehmannia, is transforming translational research by targeting multiple disease pathways. This article synthesizes mechanistic evidence—including anti-inflammatory, neuroprotective, and anti-metastatic properties—while offering protocol guidance and strategic insights for translational researchers. Bridging preclinical workflows and emerging cancer data, it positions Catalpol as a keystone compound in advanced disease modeling.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page